⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9971585 | 0.75 | — | — | |
| SCHEMBL28210028 | 0.75 | — | — | |
| SCHEMBL31306 | 0.72 | — | — | |
| SCHEMBL20957496 | 0.72 | — | — | |
| SCHEMBL18631346 | 0.72 | — | — | |
| SCHEMBL30733 | 0.70 | — | — | |
| SCHEMBL7399 | 0.70 | — | — | |
| SCHEMBL14127280 | 0.70 | — | — | |
| SCHEMBL4730315 | 0.70 | — | — | |
| SCHEMBL8020741 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0813609-B1 | METHOD OF NUCLEIC ACID ANALYSIS | CANCER REC TECH LTD (GB) | 2004-10-13 | — | — | EP | claimed |
| US-6268129-B1 | MASS SPECTROMETRY OF CHARGED NUCLEIC ACID; DNA SEQUENCING | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2001-07-31 | — | — | US | claimed |
| EP-0813609-A1 | METHOD OF NUCLEIC ACID ANALYSIS | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1997-12-29 | — | — | EP | claimed |
| WO-1996027681-A1 | METHOD OF NUCLEIC ACID ANALYSIS | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1996-09-12 | — | — | WO | claimed |
| JP-11322655-A | — | — | None | — | — | JP | disclosed |
| CN-111954848-B | Photosensitive resin composition, cured product, insulating material, resin material for solder resist, and resist member | DIC株式会社 | 2024-05-03 | — | — | CN | disclosed |
| US-20220227728-A1 | Microtubule-associated protein Tau imaging compounds for Alzheimer's disease and precursors thereof | LI MING HSIN (TW) | 2022-07-21 | — | — | US | disclosed |
| CN-109153653-B | Novel compound, photocurable composition, cured product thereof, printing ink, and printed matter using the printing ink | DIC株式会社 | 2022-06-28 | — | — | CN | disclosed |
| US-20210338849-A1 | COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS | MASSACHUSETTS GEN HOSPITAL (US) | 2021-11-04 | — | — | US | disclosed |
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | DIC CORPORATION (JP) | 2021-08-03 | — | — | US | disclosed |
| EP-3231804-B1 | COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS | MASSACHUSETTS GEN HOSPITAL (US) | 2021-03-03 | — | — | EP | disclosed |
| US-10857247-B2 | Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders | THE GENERAL HOSPITAL CORPORATION (US) | 2020-12-08 | — | — | US | disclosed |
| WO-1996027681-A1 | METHOD OF NUCLEIC ACID ANALYSIS | IMPERIAL CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 1996-09-12 | — | — | WO | disclosed |
| CN-1097736-A | New anti-arrhythmic agents and preparation method thereof | HAESSLE AB (SE) | 1995-01-25 | — | — | CN | disclosed |
| WO-1994006783-A1 | BENZOXAZOLE AND BENZOTHIAZOLE DERIVATIVES | ZENECA LIMITED (GB) | 1994-03-31 | — | — | WO | disclosed |
| EP-0322390-B1 | NOVEL ANTIARRHYTHMIC AGENTS I | Aktiebolaget Hässle (SE) | 1992-11-11 | — | — | EP | disclosed |
| US-5155133-A | Antiarrhythmic compounds and pharmaceutical compositions and methods thereof | AKTIEBOLAGET HASSLE (SE) | 1992-10-13 | — | — | US | disclosed |
| CN-1033804-A | Novel antiarrhythmic agents and process for their preparation | HAESSLE AB (SE) | 1989-07-12 | — | — | CN | disclosed |
| WO-1989005794-A1 | NOVEL ANTIARRHYTHMIC AGENTS I | Aktiebolaget Hässle (SE) | 1989-06-29 | — | — | WO | disclosed |
| EP-0322390-A2 | Novel antiarrhythmic agents I | Aktiebolaget Hässle (SE) | 1989-06-28 | — | — | EP | disclosed |